Knowthestock.com
COO - Cooper Companies, Inc.
SNP 500

Sell

Moderate Growth but Declining
WeakStrong
WeakStrong

52%

based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 44.1%
Operating Income Growth is 1.98%
Net Income Growth is -22.49%
Earnings Per Share (EPS) Growth is -22.46%
Net Margin is 7.93%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.86
Debt Ratio is 0.36
Current Debt to Net Income Ratio is 0.57
Total Debt to Total Assets Ratio is 0.23
Cash Flow is WEAK
Cash from Operations Growth is -18.67%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is Low
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Cooper Companies, Inc. (COO) - https://www.coopercos.com/
company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.
Exchange - NASDAQ
Industry - Surgical Appliance and Supplies Manufacturing
Sector - Manufacturing
CEO - Albert White
Employees - 308
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.